Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of postpartum hemorrhage after cesarean section
IRCT20231023059817N3Phase 3Completed
- Sponsor
- Pars Behrouzan Jam
- Start
- Jul 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Carbetocin with Oxytocin (2 arms). Primary endpoint: Postpartum hemorrhage. Started Jul 2024; status: completed.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20231023059817N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231023059817N3.